Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy

Clinical trial NCT01384253 · COMPLETED

Trial details

NCT number: NCT01384253
Sponsor: Orano Med LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms Peritoneal Neoplasms Ovarian Neoplasms Pancreatic Neoplasms Stomach Neoplasms

Start date: 2011-07-01
Primary completion: 2015-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.